UnitedHealth is seeking a Trump meeting as DOJ and Medicare probes pressure its $100 billion Advantage business. CEO Stephen Hemsley has met senior White House and Medicare officials while doubling lobbying spend to $7.7 million in H1 2025, hiring Trump-linked allies. Retail traders on Stocktwits remain bullish, eyeing $380-$400 levels despite the stock's 29.5% YTD decline.